Chulabhorn Hospital / Chulabhorn Royal Academy
A royal-founded cancer hospital in Bangkok specialising in advanced diagnostics and nuclear medicine, home to Thailand's first cyclotron-based PET and radioligand therapy programme.
Chulabhorn Hospital opened in 2009 under the patronage of Princess Chulabhorn as a specialist cancer hospital attached to the Chulabhorn Research Institute, later becoming part of the Chulabhorn Royal Academy with its own college of medical science. It was established to bring advanced cancer diagnostics and treatment to Thai patients regardless of means, and is known for molecular imaging and nuclear medicine, including PSMA and DOTATATE PET and lutetium and actinium radioligand therapy, for a national cancer screening and early detection programme in underserved provinces, and for chemical carcinogenesis research at the Chulabhorn Research Institute. The academy operates a growing cancer centre and trains medical and allied health professionals.
- Nuclear medicine and theranostics
- Cancer screening outreach
- Chulabhorn Research Institute
- Medical education
Pages like this
not linked directly; found by shared links- InstitutionPostgraduate Institute of Medical Education and Research, Chandigarh
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, PSMA PET, Neuroendocrine tumours.
- InstitutionTUM Klinikum rechts der Isar / CCC München
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- IdeaRegional radiopharmacy hubs and harmonised transport rules for short-lived isotopes
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, Radioligand therapy (beta emitters).
- InstitutionIRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- PairingBeta radioligand → alpha radioligand
Shares Lutetium-177 dotatate, Lutetium-177 vipivotide tetraxetan, Targeted alpha therapy, Neuroendocrine tumours.
- InstitutionInselspital, Bern University Hospital / University Cancer Center Inselspital
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, PSMA PET.
- CompanyClarity Pharmaceuticals
Shares Theranostics, PSMA PET, Radioligand therapy (beta emitters), Prostate cancer.
- InstitutionEuropean Association of Nuclear Medicine
Shares Lutetium-177 dotatate, Theranostics, Lutetium-177 vipivotide tetraxetan, PET/CT.